Malachite Innovations, Inc., established in Cleveland, Ohio, in 2007, pursues a dual business strategy. Operating through its subsidiaries, the company delivers health and wellness products across the United States, featuring a comprehensive collection of nearly 100 innovative cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The firm is also advancing the development of THC-glycoside (VBX-100), an oral prodrug intended for treating gastrointestinal conditions such as inflammatory bowel disease and irritable bowel syndrome.